-
Mashup Score: 11
We read with great interest the recent paper titled “Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?”. There was a debate among the authors about whether hepatocellular carcinoma (HCC) patients with portal vein tumour thrombosis (PVTT) are candidates for liver transplantation (LT). Soin et al. reported significant long-term survival benefits from liver transplantation in HCC and PVTT patients after successful downstaging. However, Lesurtel et al.
Source: www.journal-of-hepatology.euCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 9Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and in liver transplant recipients - 6 month(s) ago
Comparative assessments of immunogenicity following different COVID-19 vaccines in patients with distinct liver diseases are lacking. SARS-CoV-2 specific T cell and antibody responses were evaluated longitudinally after one to three vaccines alongside COVID-19 clinical outcomes.
Source: www.journal-of-hepatology.euCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 22Gilbert’s syndrome revisited - 9 month(s) ago
Gilbert’s syndrome, also known as benign hyperbilirubinaemia, was described more than 100 years ago. It has usually been considered a physiological abnormality characterised by a mild elevation of the systemic level of unconjugated bilirubin, in the absence of any underlying liver or overt haemolytic disease. However, since the re-discovery of the potent antioxidant effects of bilirubin in the late 1980s, as well as multiple intracellular signalling pathways affected by bilirubin, an ever-increasing body of evidence suggests that individuals with Gilbert’s syndrome may benefit from the mild hyperbilirubinaemia and are actually protected from the development of a wide variety of “diseases of civilisation” such as cardiovascular diseases, certain cancers, and autoimmune or neurodegenerative diseases.
Source: www.journal-of-hepatology.euCategories: Hematologists1, Latest HeadlinesTweet
Patients with Hepatocellular carcinoma and portal vein tumour thrombosis after successful downstaging may be candidates for liver transplantation:A meta-analysis #some4surgery https://t.co/eIZOc2Ubku